Immuron Reveals New Award For Naval Medical Research Command And Walter Reed Army Institute Of Research To Advance Travelan; $2.3M Funding Is Approved By The U.S. Department of Defense
Portfolio Pulse from Benzinga Newsdesk
Immuron has received a $2.3M award from the U.S. Department of Defense to advance Travelan, focusing on enhancing its formulation to target key enteric bacterial pathogens. The research will involve the Naval Medical Research Command and Walter Reed Army Institute of Research.
August 16, 2024 | 10:05 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Immuron has been awarded $2.3M by the U.S. Department of Defense to develop an enhanced formulation of Travelan, potentially expanding its coverage against key enteric bacterial pathogens.
The $2.3M funding from the U.S. Department of Defense is a significant boost for Immuron, enabling the development of an enhanced Travelan formulation. This could lead to expanded product coverage and potential revenue growth.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100